Candida rugosa: A possible emerging cause of candidaemia in trauma patients

Infection

Volumn 38, Issue 5, 2010, Pages 387-393

  Behera, B ^a   Singh, R I ^a   Xess, I ^a   Mathur, P ^a   Hasan, F ^a   Misra, M C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Candida rugosa; Candidaemia; Trauma

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; GENOMIC DNA; VORICONAZOLE;

ADOLESCENT; ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD ANALYSIS; CANDIDA RUGOSA; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEATH; EMERGENCY HEALTH SERVICE; FEMALE; FUNGUS ISOLATION; GENETIC TRAIT; HUMAN; INDIA; MALE; RANDOM AMPLIFIED POLYMORPHIC DNA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 77957671252     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0044-x     Document Type: Article

References (18)

1. V Krcmery AJ Barnes 2002 Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance J Hosp Infect 50 243 260 1:STN:280:DC%2BD383nsV2itA%3D%3D 10.1053/jhin.2001.1151 12014897
2. LR Minces KS Ho PJ Veldkamp CJ Clancy 2009 Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature Scand J Infect Dis 41 892 897 10.3109/00365540903161531 19922077
3. P Domínguez de María JM Sánchez-Montero JV Sinisterra AR Alcántara 2006 Understanding Candida rugosa lipases: an overview Biotechnol Adv 24 180 196 10.1016/j.biotechadv.2005.09.003 16288844
4. WM Crawshaw NR MacDonald G Duncan 2005 Outbreak of Candida rugosa mastitis in a dairy herd after intramammary antibiotic treatment Vet Rec 156 812 813 1:STN:280:DC%2BD2MzhslantA%3D%3D 15965006
5. I Xess N Jain F Hasan P Mandal U Banerjee 2007 Epidemiology of candidemia in a tertiary care centre of north India: 5-year study Infection 35 256 259 1:STN:280:DC%2BD2svlsleltw%3D%3D 10.1007/s15010-007-6144-6 17646917
6. ML Wilson MP Weinstein LB Reller 1994 Automated blood culture systems Clin Lab Med 14 149 169 1:STN:280:DyaK2c3js1yqtw%3D%3D 8181228
7. Segal E, Elad D. Candida species and Blastoschizomyces capitatus. In: Collier L, Balows A, Sussman M, editors. Topley & Wilson's microbiology and microbial infections, vol IV, 9th edn. New York: Oxford University Press; 1998:423-60.
8. DR Hospenthal ML Beckius KL Floyd LL Horvath CK Murray 2006 Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida Ann Clin Microbiol Antimicrob 5 1 10.1186/1476-0711-5-1 16390552
9. CL Aubertine M Rivera SM Rohan DH Larone 2006 Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card J Clin Microbiol 44 227 228 1:CAS:528:DC%2BD28XhtVymtLs%3D 10.1128/JCM.44.1.227-228. 2006 16390976
10. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A3, 3rd edn. Wayne: CLSI; 2008.
11. MA Pfaller DJ Diekema GW Procop MG Rinaldi 2007 Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol 45 796 802 1:CAS:528:DC%2BD2sXktFOgsbk%3D 10.1128/JCM.01986-06 17215344
12. MA Pfaller DJ Diekema JH Rex A Espinel-Ingroff EM Johnson D Andes V Chaturvedi MA Ghannoum FC Odds MG Rinaldi DJ Sheehan P Troke TJ Walsh DW Warnock 2006 Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints J Clin Microbiol 44 819 826 1:STN:280:DC%2BD287ivFOmtQ%3D%3D 10.1128/JCM.44.3.819-826. 2006 16517860
13. G Schönian O Meusel HJ Tietz W Meyer Y Gräser I Tausch W Presber TG Mitchell 1993 Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction Mycoses 36 171 179 10.1111/j.1439-0507.1993.tb00746.x 8264713
14. MA Pfaller DJ Diekema AL Colombo C Kibbler KP Ng DL Gibbs VA Newell 2006 Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program J Clin Microbiol 44 3578 3582 1:CAS:528:DC%2BD28XhtFyktL%2FE 10.1128/JCM.00863-06 17021085
15. AL Colombo AS Melo RF Crespo Rosas R Salomão M Briones RJ Hollis SA Messer MA Pfaller 2003 Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy Diagn Microbiol Infect Dis 46 253 257 10.1016/S0732-8893(03)00079-8 12944016
16. AM Sugar DA Stevens 1985 Candida rugosa in immunocompromised Infection. Case reports, drug susceptibility, and review of the literature Cancer 56 318 320 1:STN:280:DyaL2M3islyktw%3D%3D 10.1002/1097-0142(19850715)56:2<318::AID- CNCR2820560219>3.0.CO;2-4 3859361
17. L Ostrosky-Zeichner JH Rex PG Pappas RJ Hamill RA Larsen HW Horowitz WG Powderly N Hyslop CA Kauffman J Cleary JE Mangino J Lee 2003 Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States Antimicrob Agents Chemother 47 3149 3154 1:CAS:528:DC%2BD3sXnvVWmsbY%3D 10.1128/AAC.47.10.3149-3154.2003 14506023
18. MA Pfaller DJ Diekema 2004 Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus J Clin Microbiol 42 4419 4431 1:CAS:528:DC%2BD2cXpvFKqtLw%3D 10.1128/JCM.42.10.4419-4431.2004 15472288